Research and Development at West Bengal Chemical Industries Limited (R&D)
Our team at West Bengal Chemical Industries Limited, is composed of industry-leading experts supported by cutting-edge resources. West Bengal Chemical Industries houses state-of-the-art equipment, technology, and instrumentation, empowering our research staff to excel in overall development of API. Leveraging advanced tools, we masterfully navigate product development, manufacturing, quality assurance, and technical support.
Our Research and Development (R&D) team is the innovation engine of our company. By blending scientific expertise with market demands, we conceive and develop new products. Our rigorous research and development process ensure we stay ahead of industry trends and deliver cutting-edge solutions to our customers.
Quality is at the core of our operations. Our Quality Control (QC) department maintains unwavering vigilance over the production process. Through precise testing and analysis, we guarantee that every product meets our stringent quality standards. Our commitment to excellence ensures customer satisfaction and trust.
Quality Assurance (QA) is our commitment to delivering exceptional products. We implement comprehensive quality systems to prevent defects and ensure consistency. By continuously monitoring and improving our processes, we create a culture of quality that permeates every aspect of our business.
Our Product Evaluation Process
- Elemental and molecular composition: Dual Channel IC, HPLC, GC, GC-MS, FT-IR, NIR, UV-Vis
- Crystalline structure: XRD
- Particle size and distribution: Coulter Laser Diffraction
- Purity assessment: TOC
- Thermal behavior and stability: TGA, DSC, SDT, SA
- Product structure and morphology: Microscopy
- Product functionality and consistency: Specialized testing
The WBCIL Journal – Leading Pharma Research
| Sep 04, 2024 | Coral Calcium: A Superior Marine-Derived Calcium Supplement manufactured by WBCIL for Bone Health and beyond | Open the Pdf Visit the Link |
| Jul 26, 2024 | Liposomal Iron: A novel approach for improved iron supplementation, manufactured by WBCIL | Open the Pdf Visit the Link |
| Jul 11, 2024 | Quest Journals: Specialized Manufacturing of Calcium Lactate Gluconate (CLG) | Open the Pdf Visit the Link |
| Nov 25, 2023 | IJFMR: Safety and Efficacy of FCM in the Management of Iron Deficiency Anaemia | Open the Pdf Visit the Link |
| Oct 10, 2023 | IJSR: Evaluation of Hypersensitivity Reactions to Ferric Carboxymaltose in Iron | Open the Pdf Visit the Link |
| Products Name | CAS No. | Therapeutic Area | R&D Status |
|---|---|---|---|
| Calcium Orotate | 22454-86-0 | Calcium supplement, B13-Cal | Under Development |
| Calcium D Saccharate USP | 5793-89-5 | Hypertension, Osteoporosis, Colon Cancer | Under Scale Up |
| Magnesium Pidolate EP | 135701-98-3 | Hemoglobin Sickle cell disease for children, Hypomagnesemia (Prophylaxis) Oral | Under Development |
| Calcium Pidolate | 31377-05-6 | Osteoporosis | Developed |
| Calcium Levulinate Dihydrate USP | 34717-03-8 | Food Fortifier | Developed |
| Magnesium Aspartate Dihydrate BP | 215533-00-9 | Mineral Supplement | Under Scale Up |
| Methylcobalamine | 13422-55-4 | Deficiency of Vitamin B12, production of red blood cell | Under Development |
| Leucovorin Calcium (Purity 80% by HPLC) | 1492-18-8 | Colorectal Cancer | Under Development |
| L-Ornithin-L-Aspartate | 3230-94-2 | Hepatic Encephalopathy used also as Antihistamines. | Under Development |
| Magnesium lactate gluconate | - | Low tasting source of magnesium in food, beverage and in nutritional supplement application | Developed |
| Magnesium Orotate | 34717-03-8 | Mineral Supplement to treat Magnesium Deficiency | Developed |
| Calcium Orotate | |
|---|---|
| CAS No. | 22454-86-0 |
| Therapeutic Area | Calcium supplement, B13-Cal |
| R&D Status | Under Development |
| Calcium D Saccharate USP | |
|---|---|
| CAS No. | 5793-89-5 |
| Therapeutic Area | Hypertension, Osteoporosis, Colon Cancer |
| R&D Status | Under Scale Up |
| Magnesium Pidolate EP | |
|---|---|
| CAS No. | 135701-98-3 |
| Therapeutic Area | Hemoglobin Sickle cell disease for children, Hypomagnesemia (Prophylaxis) Oral |
| R&D Status | Under Development |
| Calcium Pidolate | |
|---|---|
| CAS No. | 31377-05-6 |
| Therapeutic Area | Osteoporosis |
| R&D Status | Developed |
| Calcium Levulinate Dihydrate USP | |
|---|---|
| CAS No. | 34717-03-8 |
| Therapeutic Area | Food Fortifier |
| R&D Status | Developed |
| Magnesium Aspartate Dihydrate BP | |
|---|---|
| CAS No. | 215533-00-9 |
| Therapeutic Area | Mineral Supplement |
| R&D Status | Under Scale Up |
| Methylcobalamine | |
|---|---|
| CAS No. | 13422-55-4 |
| Therapeutic Area | Deficiency of Vitamin B12, production of red blood cell |
| R&D Status | Under Development |
| Leucovorin Calcium (Purity 80% by HPLC) | |
|---|---|
| CAS No. | 1492-18-8 |
| Therapeutic Area | Colorectal Cancer |
| R&D Status | Under Development |
| L-Ornithin-L-Aspartate | |
|---|---|
| CAS No. | 3230-94-2 |
| Therapeutic Area | Hepatic Encephalopathy used also as Antihistamines. |
| R&D Status | Under Development |
| Magnesium lactate gluconate | |
|---|---|
| CAS No. | - |
| Therapeutic Area | Low tasting source of magnesium in food, beverage and in nutritional supplement application |
| R&D Status | Developed |
| Magnesium Orotate | |
|---|---|
| CAS No. | 34717-03-8 |
| Therapeutic Area | Mineral Supplement to treat Magnesium Deficiency |
| R&D Status | Developed |